- What's New 0302.PMD
Dear Doctor Letter regarding Kava Kava The FDA communicates information about serious events or problems encountered with medical products using different means, including press releases, articles in professional journals and with industry through what.
- Kava lactones and the kava-kava controversy
Epidemiological studies carried out in the traditional extracts of kava have been taken by individuals regularly in quantities equivalent to between ten and 50 times the recommended daily dose of kava lactones, no evidence of liver damage has been seen.
- Kava: a test case for Canada’s new approach to natural health
Commentary Commentaire Kava: a test case for Canada s new approach to natural health products Heather S.Boon, Albert H.C.Wong See related article page 1158 kava had been the subject of a Health Canada advisory,2 employees in 22 (67%) of the 33 stores.
- Dear Health Care Professional Colleague: The Food and Drug
Approximately 25 reports of hepatic toxicity associated with the use of products containing kava extracts have been reported in these countries... Bono para apoyar negocio, viajes de TAC y RSC, etc tera.
- Sale of kava extract in some health food stores
These findings demonstrate that health food stores may need to be better informed about the sale of restricted natural health products... Bono para apoyar negocio, viajes de TAC y RSC, etc tera.
|
